120 related articles for article (PubMed ID: 38531660)
1. Role of Wnt5b-Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells.
Yamauchi N; Otsuka M; Ishikawa T; Kakeji Y; Kikuchi A; Masuda A; Kodama Y; Minami Y; Kamizaki K
Genes Cells; 2024 Jun; 29(6):503-511. PubMed ID: 38531660
[TBL] [Abstract][Full Text] [Related]
2. Role of the Ror family receptors in Wnt5a signaling.
Kamizaki K; Minami Y; Nishita M
In Vitro Cell Dev Biol Anim; 2024 May; 60(5):489-501. PubMed ID: 38587578
[TBL] [Abstract][Full Text] [Related]
3. ROR1 and ROR2 expression in pancreatic cancer.
Liu D; Sharbeen G; Phillips P; ; Ford CE
BMC Cancer; 2021 Nov; 21(1):1199. PubMed ID: 34763666
[TBL] [Abstract][Full Text] [Related]
4. YAP/BRD4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in pancreatic cancer.
Yamazaki M; Hino S; Usuki S; Miyazaki Y; Oda T; Nakao M; Ito T; Yamagata K
EMBO J; 2023 Jul; 42(14):e112614. PubMed ID: 37096681
[TBL] [Abstract][Full Text] [Related]
5. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
Endo M; Doi R; Nishita M; Minami Y
J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
[TBL] [Abstract][Full Text] [Related]
6. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell-derived CXCL16 promotes progression of gastric cancer cells by STAT3-mediated expression of Ror1.
Ikeda T; Nishita M; Hoshi K; Honda T; Kakeji Y; Minami Y
Cancer Sci; 2020 Apr; 111(4):1254-1265. PubMed ID: 32012403
[TBL] [Abstract][Full Text] [Related]
9. The WNT5A/ROR2 signaling pathway in pancreatic ductal adenocarcinoma (PDAC).
Remtisch L; Wiltberger G; Schierle K; Yousef M; Thieme R; Jansen Winkeln B; Wittekind C; Gockel I; Lyros O
J BUON; 2021; 26(4):1595-1606. PubMed ID: 34565024
[TBL] [Abstract][Full Text] [Related]
10. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma.
Yang T; Shen P; Chen Q; Wu P; Yuan H; Ge W; Meng L; Huang X; Fu Y; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
J Exp Clin Cancer Res; 2021 Aug; 40(1):261. PubMed ID: 34416910
[TBL] [Abstract][Full Text] [Related]
11. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity.
Si W; Liu X; Wei R; Zhang Y; Zhao Y; Cui L; Hong T
Cell Death Dis; 2019 Feb; 10(3):206. PubMed ID: 30814496
[TBL] [Abstract][Full Text] [Related]
12. Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survival.
Mittelstädt A; Anthuber A; David P; Podolska M; Bénard A; Brunner M; Krautz C; Jacobsen A; Denz A; Weber K; Merkel S; Hackner D; Buniatov T; Roßdeutsch L; Klösch B; Swierzy I; Hansen FJ; Strobel D; Zopf Y; Baur JO; Van Deun J; Immanuel Geppert C; Gießl A; Lettmaier S; Semrau S; Grützmann R; Kouhestani D; Weber GF
Front Immunol; 2024; 15():1253072. PubMed ID: 38846943
[TBL] [Abstract][Full Text] [Related]
13. ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth.
Zhang S; Chen L; Cui B; Chuang HY; Yu J; Wang-Rodriguez J; Tang L; Chen G; Basak GW; Kipps TJ
PLoS One; 2012; 7(3):e31127. PubMed ID: 22403610
[TBL] [Abstract][Full Text] [Related]
14. Diverse regulation of mammary epithelial growth and branching morphogenesis through noncanonical Wnt signaling.
Kessenbrock K; Smith P; Steenbeek SC; Pervolarakis N; Kumar R; Minami Y; Goga A; Hinck L; Werb Z
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3121-3126. PubMed ID: 28270600
[TBL] [Abstract][Full Text] [Related]
15. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
16. SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression.
Liu M; Shi Y; Hu Q; Qin Y; Ji S; Liu W; Zhuo Q; Fan G; Ye Z; Song C; Yu X; Xu X; Xu W
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1614-1624. PubMed ID: 34599596
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
19. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
20. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
